Clinical trial

Real World Difference After Changing Medication From Nonselective to Selective Endothelin Receptor Antagonist in Stable Eisenmenger Syndrome

NCT04732650

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2021-02-04

PhaseN/A

Study timeline

Study start (estimated)2021-02-04Date precision: day

Registry last updated2021-02-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Eisenmenger Complexunresolved

Interventions

Sponsors & collaborators

Samsung Medical Centerlead sponsor

GlaxoSmithKlinecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04732650 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.